scPharmaceuticals Ownership 2024 | Who Owns scPharmaceuticals Now?
Institutional Ownership
71.15%
Insider Ownership
8.46%
Retail Ownership
20.39%
Institutional Holders
73.00
scPharmaceuticals Institutional Shareholders
Institutional Shareholders by % of Total Shares
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| ORBIMED ADVISORS LLC | 14.27% | 0.48% | 5,559,528 | - | - | 24,183,947 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 9.05% | 0.40% | 3,525,000 | - | - | 15,333,750 | Jun 30, 2024 |
| AIGH CAPITAL MANAGEMENT LLC | 9.00% | 4.75% | 3,504,365 | 115,206 | 3.40% | 15,243,987 | Jun 30, 2024 |
| KING LUTHER CAPITAL MANAGEMENT CORP | 5.66% | 0.04% | 2,205,140 | 752,005 | 51.75% | 9,592,359 | Jun 30, 2024 |
| BLACKROCK INC. | 4.54% | 0.00% | 1,768,669 | -32,941 | -1.83% | 7,693,709 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.56% | 0.00% | 1,386,196 | 16,360 | 1.19% | 6,029,952 | Jun 30, 2024 |
| 5AM VENTURE MANAGEMENT, LLC | 3.08% | 1.17% | 1,200,647 | - | - | 5,222,814 | Jun 30, 2024 |
| THRIVENT FINANCIAL FOR LUTHERANS | 2.65% | 0.01% | 1,034,072 | -32,632 | -3.06% | 4,499,000 | Jun 30, 2024 |
| J. GOLDMAN & CO LP | 2.23% | 0.11% | 870,337 | -248,308 | -22.20% | 3,785,966 | Jun 30, 2024 |
| TEJARA CAPITAL LTD | 1.81% | 1.11% | 704,742 | 6,556 | 0.94% | 3,065,628 | Jun 30, 2024 |
| STATE STREET CORP | 1.66% | 0.00% | 648,256 | 72,990 | 12.69% | 2,819,914,000 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.49% | 0.00% | 581,760 | 39,917 | 7.37% | 2,530,920 | Jun 30, 2024 |
| RICE HALL JAMES & ASSOCIATES, LLC | 1.28% | 0.13% | 497,227 | 216,122 | 76.88% | 2,162,937 | Jun 30, 2024 |
| STONEPINE CAPITAL MANAGEMENT, LLC | 1.08% | 1.68% | 421,703 | -25,073 | -5.61% | 1,834,408 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.96% | 0.00% | 374,407 | -181,779 | -32.68% | 1,628,670 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.90% | 0.00% | 351,806 | 351,806 | 100.00% | 1,544,428 | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.64% | 0.00% | 247,922 | -16,887 | -6.38% | 1,078,460,000 | Jun 30, 2024 |
| MORGAN STANLEY | 0.57% | 0.00% | 221,291 | 40,571 | 22.45% | 962,615 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.57% | 0.00% | 221,000 | -14,958 | -6.34% | 961,350 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 0.56% | 0.02% | 218,812 | -942 | -0.43% | 951,832 | Jun 30, 2024 |
scPharmaceuticals's largest institutional shareholder is ORBIMED ADVISORS LLC, holding 14.27% of the company's total share outstanding, currently valued at $24.18M. The top 10 institutional shareholders own together 55.86% of the company.
Institutional Shareholders by % of Total Assets
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AIGH CAPITAL MANAGEMENT LLC | 9.00% | 4.75% | 3,504,365 | 115,206 | 3.40% | 15,243,987 | Jun 30, 2024 |
| STONEPINE CAPITAL MANAGEMENT, LLC | 1.08% | 1.68% | 421,703 | -25,073 | -5.61% | 1,834,408 | Jun 30, 2024 |
| 5AM VENTURE MANAGEMENT, LLC | 3.08% | 1.17% | 1,200,647 | - | - | 5,222,814 | Jun 30, 2024 |
| TEJARA CAPITAL LTD | 1.81% | 1.11% | 704,742 | 6,556 | 0.94% | 3,065,628 | Jun 30, 2024 |
| ORBIMED ADVISORS LLC | 14.27% | 0.48% | 5,559,528 | - | - | 24,183,947 | Jun 30, 2024 |
| RUBRIC CAPITAL MANAGEMENT LP | 9.05% | 0.40% | 3,525,000 | - | - | 15,333,750 | Jun 30, 2024 |
| BALANCED ROCK INVESTMENT ADVISOR | 0.16% | 0.23% | 63,130 | 5,882 | 10.27% | 274,616 | Jun 30, 2024 |
| RICE HALL JAMES & ASSOCIATES, LLC | 1.28% | 0.13% | 497,227 | 216,122 | 76.88% | 2,162,937 | Jun 30, 2024 |
| J. GOLDMAN & CO LP | 2.23% | 0.11% | 870,337 | -248,308 | -22.20% | 3,785,966 | Jun 30, 2024 |
| PERKINS CAPITAL MANAGEMENT INC | 0.05% | 0.08% | 18,400 | 7,800 | 73.58% | 80,000 | Jun 30, 2024 |
| KING LUTHER CAPITAL MANAGEMENT CORP | 5.66% | 0.04% | 2,205,140 | 752,005 | 51.75% | 9,592,359 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.07% | 0.02% | 29,086 | 14,664 | 101.68% | 126,524 | Jun 30, 2024 |
| SANDY COVE ADVISORS, LLC | 0.03% | 0.02% | 10,592 | - | - | 46,075 | Jun 30, 2024 |
| KENNEDY CAPITAL MANAGEMENT LLC | 0.56% | 0.02% | 218,812 | -942 | -0.43% | 951,832 | Jun 30, 2024 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 0.49% | 0.02% | 189,000 | - | - | 822,150 | Jun 30, 2024 |
| THOMASVILLE NATIONAL BANK | 0.10% | 0.01% | 37,500 | 700 | 1.90% | 163,125 | Jun 30, 2024 |
| IPG INVESTMENT ADVISORS LLC | 0.03% | 0.01% | 12,000 | - | - | 52,200 | Jun 30, 2024 |
| THRIVENT FINANCIAL FOR LUTHERANS | 2.65% | 0.01% | 1,034,072 | -32,632 | -3.06% | 4,499,000 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.04% | 0.01% | 17,351 | 17,351 | 100.00% | 75,477 | Jun 30, 2024 |
| PINNACLE WEALTH PLANNING SERVICES, INC. | 0.03% | 0.01% | 11,232 | 11,232 | 100.00% | 48,859 | Jun 30, 2024 |
The largest scPharmaceuticals shareholder by % of total assets is AIGH CAPITAL MANAGEMENT LLC. The company owns 3.50M shares of scPharmaceuticals (SCPH), representing 4.75% of its total assets.
Institutional Buyers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| KING LUTHER CAPITAL MANAGEMENT CORP | 5.66% | 0.04% | 2,205,140 | 752,005 | 51.75% | 9,592,359 | Jun 30, 2024 |
| BANK OF MONTREAL /CAN/ | 0.90% | 0.00% | 351,806 | 351,806 | 100.00% | 1,544,428 | Jun 30, 2024 |
| RICE HALL JAMES & ASSOCIATES, LLC | 1.28% | 0.13% | 497,227 | 216,122 | 76.88% | 2,162,937 | Jun 30, 2024 |
| AIGH CAPITAL MANAGEMENT LLC | 9.00% | 4.75% | 3,504,365 | 115,206 | 3.40% | 15,243,987 | Jun 30, 2024 |
| STATE STREET CORP | 1.66% | 0.00% | 648,256 | 72,990 | 12.69% | 2,819,914,000 | Jun 30, 2024 |
| ASSENAGON ASSET MANAGEMENT S.A. | 0.19% | 0.00% | 72,692 | 52,870 | 266.72% | 316,210 | Jun 30, 2024 |
| MORGAN STANLEY | 0.57% | 0.00% | 221,291 | 40,571 | 22.45% | 962,615 | Jun 30, 2024 |
| GEODE CAPITAL MANAGEMENT, LLC | 1.49% | 0.00% | 581,760 | 39,917 | 7.37% | 2,530,920 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.04% | 0.01% | 17,351 | 17,351 | 100.00% | 75,477 | Jun 30, 2024 |
| VANGUARD GROUP INC | 3.56% | 0.00% | 1,386,196 | 16,360 | 1.19% | 6,029,952 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 15,274 | 15,274 | 100.00% | 66,442 | Jun 30, 2024 |
| SHERBROOKE PARK ADVISERS LLC | 0.07% | 0.02% | 29,086 | 14,664 | 101.68% | 126,524 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 14,643 | 14,643 | 100.00% | 63,697 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.04% | 0.00% | 13,995 | 13,995 | 100.00% | 60,878 | Jun 30, 2024 |
| VOYA INVESTMENT MANAGEMENT LLC | 0.03% | 0.00% | 11,501 | 11,501 | 100.00% | 50,029 | Jun 30, 2024 |
| BANK OF NEW YORK MELLON CORP | 0.22% | 0.00% | 86,101 | 11,269 | 15.06% | 374,541 | Jun 30, 2024 |
| PINNACLE WEALTH PLANNING SERVICES, INC. | 0.03% | 0.01% | 11,232 | 11,232 | 100.00% | 48,859 | Jun 30, 2024 |
| INVESCO LTD. | 0.06% | - | 22,658 | 9,955 | 78.37% | 98,563 | Jun 30, 2024 |
| BANK OF AMERICA CORP /DE/ | 0.10% | - | 37,916 | 9,637 | 34.08% | 164,934 | Jun 30, 2024 |
| PERKINS CAPITAL MANAGEMENT INC | 0.05% | 0.08% | 18,400 | 7,800 | 73.58% | 80,000 | Jun 30, 2024 |
As of Jun 30 2024, scPharmaceuticals's largest institutional buyer is KING LUTHER CAPITAL MANAGEMENT CORP. The company purchased 752.00K stocks of SCPH, valued at $9.59M.
Institutional Sellers
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| J. GOLDMAN & CO LP | 2.23% | 0.11% | 870,337 | -248,308 | -22.20% | 3,785,966 | Jun 30, 2024 |
| WALLEYE CAPITAL LLC | 0.96% | 0.00% | 374,407 | -181,779 | -32.68% | 1,628,670 | Jun 30, 2024 |
| AMERIPRISE FINANCIAL INC | - | - | - | -85,863 | -100.00% | - | Jun 30, 2024 |
| MILLENNIUM MANAGEMENT LLC | 0.33% | 0.00% | 130,070 | -59,014 | -31.21% | 565,804 | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| SQUAREPOINT OPS LLC | 0.05% | 0.00% | 19,554 | -42,709 | -68.59% | 85,060 | Jun 30, 2024 |
| BLACKROCK INC. | 4.54% | 0.00% | 1,768,669 | -32,941 | -1.83% | 7,693,709 | Jun 30, 2024 |
| THRIVENT FINANCIAL FOR LUTHERANS | 2.65% | 0.01% | 1,034,072 | -32,632 | -3.06% | 4,499,000 | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -32,532 | -100.00% | - | Jun 30, 2024 |
| DIMENSIONAL FUND ADVISORS LP | 0.35% | 0.00% | 135,080 | -31,136 | -18.73% | 587,638 | Jun 30, 2024 |
| UBS GROUP AG | 0.02% | - | 8,770 | -25,464 | -74.38% | 38,150 | Jun 30, 2024 |
| STONEPINE CAPITAL MANAGEMENT, LLC | 1.08% | 1.68% | 421,703 | -25,073 | -5.61% | 1,834,408 | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -17,895 | -100.00% | - | Jun 30, 2024 |
| NORTHERN TRUST CORP | 0.64% | 0.00% | 247,922 | -16,887 | -6.38% | 1,078,460,000 | Jun 30, 2024 |
| RENAISSANCE TECHNOLOGIES LLC | 0.57% | 0.00% | 221,000 | -14,958 | -6.34% | 961,350 | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -14,232 | -100.00% | - | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | - | - | - | -12,301 | -100.00% | - | Jun 30, 2024 |
| BNP PARIBAS ARBITRAGE, SNC | 0.01% | - | 2,652 | -11,734 | -81.57% | 11,536 | Jun 30, 2024 |
| BARCLAYS PLC | 0.03% | - | 9,742 | -10,562 | -52.02% | 43,000 | Jun 30, 2024 |
| METLIFE INVESTMENT MANAGEMENT, LLC | 0.02% | 0.00% | 7,222 | -8,082 | -52.81% | 31,416 | Jun 30, 2024 |
As of Jun 30 2024, scPharmaceuticals's biggest institutional seller is J. GOLDMAN & CO LP. The company sold -0.25M shares of SCPH, valued at $3.79M.
Institutional New positions
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| BANK OF MONTREAL /CAN/ | 0.90% | 0.00% | 351,806 | 351,806 | 100.00% | 1,544,428 | Jun 30, 2024 |
| PDT PARTNERS, LLC | 0.04% | 0.01% | 17,351 | 17,351 | 100.00% | 75,477 | Jun 30, 2024 |
| COREBRIDGE FINANCIAL, INC. | 0.04% | 0.00% | 15,274 | 15,274 | 100.00% | 66,442 | Jun 30, 2024 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS LTD. | 0.04% | 0.00% | 14,643 | 14,643 | 100.00% | 63,697 | Jun 30, 2024 |
| TREXQUANT INVESTMENT LP | 0.04% | 0.00% | 13,995 | 13,995 | 100.00% | 60,878 | Jun 30, 2024 |
| PINNACLE WEALTH PLANNING SERVICES, INC. | 0.03% | 0.01% | 11,232 | 11,232 | 100.00% | 48,859 | Jun 30, 2024 |
| CWM, LLC | 0.00% | - | 268 | 268 | 100.00% | 1,000 | Jun 30, 2024 |
| NISA INVESTMENT ADVISORS, LLC | 0.00% | - | 144 | 144 | 100.00% | 626 | Jun 30, 2024 |
| RUSSELL INVESTMENTS GROUP, LTD. | 0.00% | - | 44 | 44 | 100.00% | 191 | Jun 30, 2024 |
scPharmaceuticals's largest new institutional shareholder by number of shares is BANK OF MONTREAL /CAN/, purchased 351.81K shares, valued at $1.54M, as of undefined.
Institutional Sold Out
| Name | % Total Shares | % Total Assets | Current Shares | Change Amount | Change % | Market Value | Date |
|---|---|---|---|---|---|---|---|
| AMERIPRISE FINANCIAL INC | - | - | - | -85,863 | -100.00% | - | Jun 30, 2024 |
| CAPTION MANAGEMENT, LLC | - | - | - | -50,000 | -100.00% | - | Jun 30, 2024 |
| CONNOR, CLARK & LUNN INVESTMENT MANAGEMENT LTD. | - | - | - | -32,532 | -100.00% | - | Jun 30, 2024 |
| VIRTU FINANCIAL LLC | - | - | - | -17,895 | -100.00% | - | Jun 30, 2024 |
| AMERICAN INTERNATIONAL GROUP, INC. | - | - | - | -14,232 | -100.00% | - | Jun 30, 2024 |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | - | - | - | -12,301 | -100.00% | - | Jun 30, 2024 |
| WORTH VENTURE PARTNERS, LLC | - | - | - | -2,283 | -100.00% | - | Jun 30, 2024 |
| NORDWAND ADVISORS, LLC | - | - | - | -500 | -100.00% | - | Jun 30, 2024 |
| METROPOLITAN LIFE INSURANCE CO/NY | - | - | - | -343 | -100.00% | - | Jun 30, 2024 |
| FARTHER FINANCE ADVISORS, LLC | - | - | - | -59 | -100.00% | - | Jun 30, 2024 |
| NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC | - | - | - | -6 | -100.00% | - | Jun 30, 2024 |
scPharmaceuticals's largest sold out institutional shareholder by shares sold is AMERIPRISE FINANCIAL INC, sold -85.86K shares, valued at -, as of undefined.
scPharmaceuticals Mutual Fund Holders
| Name | % Total Assets | Total Shares | Change Amount | Change % | Date |
|---|---|---|---|---|---|
| BRIDGEWAY FUNDS INC | 0.08% | 186,300 | 45,000 | 31.85% | Mar 28, 2024 |
| VANGUARD VALLEY FORGE FUNDS | 0.03% | 18,200 | - | - | Mar 31, 2024 |
| DRIEHAUS MUTUAL FUNDS | 0.01% | 117,596 | - | - | Mar 28, 2024 |
| FORUM FUNDS II | 0.01% | 12,684 | - | - | Jan 31, 2024 |
| QUANTITATIVE MASTER SERIES LLC | 0.01% | 49,478 | - | - | Mar 31, 2024 |
| DEUTSCHE DWS INVESTMENTS VIT FUNDS | 0.01% | 4,473 | - | - | Mar 31, 2024 |
| CLEARWATER INVESTMENT TRUST | 0.01% | 52,986 | 38,594 | 268.16% | Mar 28, 2024 |
| THRIVENT MUTUAL FUNDS | 0.01% | 484,138 | 7,268 | 1.52% | Jan 31, 2024 |
| THRIVENT SERIES FUND INC | 0.00% | 559,914 | 8,636 | 1.57% | Mar 28, 2024 |
| AMERICAN CENTURY WORLD MUTUAL FUNDS INC | 0.00% | 36,781 | - | - | Feb 29, 2024 |
| VANGUARD INDEX FUNDS | 0.00% | 1,153,723 | -303,787 | -20.84% | Mar 31, 2024 |
| FIRST TRUST EXCHANGE-TRADED FUND | 0.00% | 23,614 | - | - | Mar 31, 2024 |
| SCHWAB CAPITAL TRUST | 0.00% | 77,411 | -181 | -0.23% | Jan 31, 2024 |
| FIDELITY CONCORD STREET TRUST | 0.00% | 213,777 | 1,353 | 0.64% | Feb 29, 2024 |
| Calvert Variable Products, Inc. | 0.00% | 2,385 | - | - | Mar 31, 2024 |
| AdvisorShares Trust | 0.00% | 3,300 | - | - | Mar 28, 2024 |
| VANGUARD INSTITUTIONAL INDEX FUNDS | 0.00% | 12,098 | -1,301 | -9.71% | Mar 31, 2024 |
| Global X Funds | 0.00% | 14,884 | - | - | Jan 31, 2024 |
| STATE STREET VARIABLE INSURANCE SERIES FUNDS INC | 0.00% | 1,641 | - | - | Mar 31, 2024 |
| GPS Funds I | 0.00% | 1,787 | - | - | Mar 31, 2024 |
| Voya VARIABLE PORTFOLIOS INC | 0.00% | 9,937 | -1,815 | -15.44% | Mar 31, 2024 |
| RBB FUND, INC. | 0.00% | 24,454 | - | - | Feb 29, 2024 |
| RUSSELL INVESTMENT CO | 0.00% | 74,324 | - | - | Jan 31, 2024 |
| NORTHERN FUNDS | 0.00% | 22,951 | -1,712 | -6.94% | Mar 28, 2024 |
| RUSSELL INVESTMENT FUNDS | 0.00% | 18,210 | - | - | Mar 31, 2024 |
| TIAA-CREF LIFE FUNDS | 0.00% | 424 | - | - | Mar 31, 2024 |
| Meeder Funds | 0.00% | 729 | - | - | Mar 31, 2024 |
| DFA INVESTMENT DIMENSIONS GROUP INC | 0.00% | 144,742 | 58,787 | 68.39% | Jan 31, 2024 |
| STATE STREET INSTITUTIONAL INVESTMENT TRUST | 0.00% | 8,900 | - | - | Mar 31, 2024 |
| SunAmerica Specialty Series | 0.00% | 58 | - | - | Apr 30, 2021 |
| Dimensional ETF Trust | 0.00% | 45,479 | - | - | Jan 31, 2024 |
| T. Rowe Price Index Trust, Inc. | 0.00% | 1,881 | 244 | 14.91% | Mar 31, 2024 |
| VANGUARD SCOTTSDALE FUNDS | 0.00% | 130,755 | 13,037 | 11.07% | Feb 29, 2024 |
| RYDEX SERIES FUNDS | 0.00% | 263 | - | - | Dec 31, 2023 |
| iSHARES TRUST | 0.00% | 1,015,068 | -60,457 | -5.62% | Mar 31, 2024 |
| Invesco Exchange-Traded Self-Indexed Fund Trust | 0.00% | 12,735 | - | - | Feb 29, 2024 |
| EQ ADVISORS TRUST | 0.00% | 62,306 | - | - | Mar 31, 2024 |
| VANGUARD WELLINGTON FUND | 0.00% | 18,971 | - | - | Feb 29, 2024 |
| VALIC Co I | 0.00% | 11,083 | -44 | -0.40% | Feb 29, 2024 |
| PENN SERIES FUNDS INC | 0.00% | 1,100 | - | - | Mar 28, 2024 |
| PGIM ETF TRUST | 0.00% | 2,454 | - | - | Feb 29, 2024 |
| NATIONWIDE MUTUAL FUNDS | 0.00% | 4,765 | -22 | -0.46% | Jan 31, 2024 |
| RYDEX DYNAMIC FUNDS | 0.00% | 131 | - | - | Dec 31, 2023 |
| NATIONWIDE VARIABLE INSURANCE TRUST | 0.00% | 4,250 | - | - | Mar 31, 2024 |
| MUTUAL FUND SERIES TRUST | 0.00% | 125,000 | - | - | Mar 31, 2024 |
| TIAA-CREF FUNDS | 0.00% | 75,727 | - | - | Jan 31, 2024 |
| Investment Managers Series Trust | 0.00% | 32,416 | - | - | Mar 31, 2024 |
| ProFunds | 0.00% | 224 | -18 | -7.44% | Mar 31, 2024 |
| ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 911 | - | - | Dec 31, 2023 |
| PROSHARES TRUST | 0.00% | 4,232 | 499 | 13.37% | Feb 29, 2024 |
| RYDEX VARIABLE TRUST | 0.00% | 17 | - | - | Dec 31, 2023 |
| SPDR SERIES TRUST | 0.00% | 550,267 | - | - | Mar 31, 2024 |
| USAA MUTUAL FUNDS TRUST | 0.00% | 3,151 | 550 | 21.15% | Jan 31, 2024 |
| COLLEGE RETIREMENT EQUITIES FUND | 0.00% | 14,352 | - | - | Mar 31, 2024 |
| Brighthouse Funds Trust II | 0.00% | 9,727 | -19 | -0.19% | Mar 31, 2024 |
| LINCOLN VARIABLE INSURANCE PRODUCTS TRUST | 0.00% | 26,003 | - | - | Mar 31, 2024 |
| MORGAN STANLEY PATHWAY FUNDS | 0.00% | 1,052 | - | - | Feb 29, 2024 |
| ALLSPRING MASTER TRUST | 0.00% | 601 | - | - | Feb 29, 2024 |
| SUNAMERICA SERIES TRUST | 0.00% | 3,272 | -13 | -0.40% | Jan 31, 2024 |
| Brinker Capital Destinations Trust | 0.00% | 530 | - | - | Feb 29, 2024 |
| JOHN HANCOCK VARIABLE INSURANCE TRUST | 0.00% | 12,246 | 94 | 0.77% | Mar 31, 2024 |
| FIDELITY SALEM STREET TRUST | 0.00% | 14,197 | 1,645 | 13.11% | Mar 31, 2024 |
| PACE SELECT ADVISORS TRUST | 0.00% | 1,000 | - | - | Jan 31, 2024 |
| PACIFIC SELECT FUND | 0.00% | 9,143 | - | - | Mar 31, 2024 |
| Bridge Builder Trust | 0.00% | 5,725 | - | - | Mar 31, 2024 |
| MASSMUTUAL SELECT FUNDS | 0.00% | 786 | - | - | Dec 31, 2023 |
| BLACKROCK FUNDS | 0.00% | 5,078 | - | - | Jan 31, 2024 |
| BlackRock Variable Series Funds, Inc. | 0.00% | 3,467 | - | - | Mar 31, 2024 |
| PRINCIPAL FUNDS, INC. | 0.00% | 4,117 | 1,109 | 36.87% | Jan 31, 2024 |
| Goldman Sachs ETF Trust | 0.00% | 25 | -3,471 | -99.28% | Feb 29, 2024 |
scPharmaceuticals's largest mutual fund holder by % of total assets is "BRIDGEWAY FUNDS INC", owning 186.30K shares, compromising 0.08% of its total assets.
scPharmaceuticals Institutional Ownership Trends
Institutional Holdings Trend
| Date | Holdings | Change % |
|---|---|---|
| 30 Jun, 24 | 73 | -9.88% |
| 31 Mar, 24 | 81 | -4.71% |
| 31 Dec, 23 | 85 | 10.39% |
| 30 Sep, 23 | 77 | -9.41% |
| 30 Jun, 23 | 85 | 28.79% |
| 31 Mar, 23 | 66 | 6.45% |
| 31 Dec, 22 | 62 | 58.97% |
| 30 Sep, 22 | 39 | 8.33% |
| 30 Jun, 22 | 36 | 2.86% |
| 31 Mar, 22 | 35 | 16.67% |
| 31 Dec, 21 | 30 | - |
| 30 Sep, 21 | 30 | -14.29% |
| 30 Jun, 21 | 35 | -22.22% |
| 31 Mar, 21 | 45 | -2.17% |
| 31 Dec, 20 | 46 | -8.00% |
| 30 Sep, 20 | 50 | -1.96% |
| 30 Jun, 20 | 51 | 59.38% |
| 31 Mar, 20 | 32 | 14.29% |
| 31 Dec, 19 | 28 | 12.00% |
| 30 Sep, 19 | 25 | -13.79% |
| 30 Jun, 19 | 29 | -9.38% |
| 31 Mar, 19 | 32 | -5.88% |
| 31 Dec, 18 | 34 | 6.25% |
| 30 Sep, 18 | 32 | -17.95% |
| 30 Jun, 18 | 39 | 2.63% |
| 31 Mar, 18 | 38 | 58.33% |
| 31 Dec, 17 | 24 | - |
As of 30 Jun 24, 73 institutions are holding scPharmaceuticals's shares, representing a decrease of -9.88% compared to the previous quarter.
Shares Outstanding Trend
| Date | Shares Outstanding | Change % |
|---|---|---|
| 30 Jun, 24 | 27,715,856 | 3.66% |
| 31 Mar, 24 | 26,737,984 | -4.32% |
| 31 Dec, 23 | 27,946,038 | -6.54% |
| 30 Sep, 23 | 29,902,963 | 4.89% |
| 30 Jun, 23 | 28,507,710 | 15.99% |
| 31 Mar, 23 | 24,576,959 | 14.95% |
| 31 Dec, 22 | 21,381,300 | 52.65% |
| 30 Sep, 22 | 14,006,513 | -10.67% |
| 30 Jun, 22 | 15,679,691 | -1.28% |
| 31 Mar, 22 | 15,882,822 | -0.33% |
| 31 Dec, 21 | 15,935,870 | -1.81% |
| 30 Sep, 21 | 16,228,956 | 1.26% |
| 30 Jun, 21 | 16,027,686 | -6.55% |
| 31 Mar, 21 | 17,151,627 | 1.22% |
| 31 Dec, 20 | 16,944,425 | -0.87% |
| 30 Sep, 20 | 17,093,699 | -2.52% |
| 30 Jun, 20 | 17,536,484 | 40.42% |
| 31 Mar, 20 | 12,488,415 | 12.26% |
| 31 Dec, 19 | 11,124,578 | 46.81% |
| 30 Sep, 19 | 7,577,681 | 2.81% |
| 30 Jun, 19 | 7,370,592 | -1.52% |
| 31 Mar, 19 | 7,483,982 | -4.63% |
| 31 Dec, 18 | 7,847,513 | -2.60% |
| 30 Sep, 18 | 8,056,850 | -0.43% |
| 30 Jun, 18 | 8,091,983 | -2.75% |
| 31 Mar, 18 | 8,320,526 | 6.58% |
| 31 Dec, 17 | 7,806,737 | - |
scPharmaceuticals (SCPH) has 27.72M shares outstanding as of 30 Jun 24, up 3.66% compared to the previous quarter.
Institutional Ownership Trend
| Date | Ownership % | Change % |
|---|---|---|
| 30 Jun, 24 | 71.15% | 1.50% |
| 31 Mar, 24 | 68.94% | 1.33% |
| 31 Dec, 23 | 72.10% | 1.21% |
| 30 Sep, 23 | 77.28% | 1.36% |
| 30 Jun, 23 | 75.42% | 1.78% |
| 31 Mar, 23 | 65.02% | 1.14% |
| 31 Dec, 22 | 75.40% | 2.89% |
| 30 Sep, 22 | 51.12% | 1.56% |
| 30 Jun, 22 | 57.27% | 1.70% |
| 31 Mar, 22 | 58.03% | 1.71% |
| 31 Dec, 21 | 58.25% | 1.65% |
| 30 Sep, 21 | 59.33% | 1.73% |
| 30 Jun, 21 | 58.59% | 1.49% |
| 31 Mar, 21 | 62.74% | 1.63% |
| 31 Dec, 20 | 62.02% | 1.58% |
| 30 Sep, 20 | 62.57% | 1.11% |
| 30 Jun, 20 | 75.09% | 1.97% |
| 31 Mar, 20 | 61.77% | 1.74% |
| 31 Dec, 19 | 59.61% | 3.59% |
| 30 Sep, 19 | 40.77% | 2.59% |
| 30 Jun, 19 | 39.67% | 2.44% |
| 31 Mar, 19 | 40.29% | 2.25% |
| 31 Dec, 18 | 42.29% | 2.25% |
| 30 Sep, 18 | 43.39% | 2.28% |
| 30 Jun, 18 | 43.62% | 2.16% |
| 31 Mar, 18 | 44.89% | 2.53% |
| 31 Dec, 17 | 42.12% | - |
As of 30 Jun 24, scPharmaceuticals is held by 71.15% institutional shareholders, representing a 1.50% growth compared to 31 Mar 24.
Institutional Increased Positions Trend
| Date | Increased Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 38 | 8.57% |
| 31 Mar, 24 | 35 | -16.67% |
| 31 Dec, 23 | 42 | 40.00% |
| 30 Sep, 23 | 30 | -46.43% |
| 30 Jun, 23 | 56 | 43.59% |
| 31 Mar, 23 | 39 | -11.36% |
| 31 Dec, 22 | 44 | 238.46% |
| 30 Sep, 22 | 13 | -27.78% |
| 30 Jun, 22 | 18 | 38.46% |
| 31 Mar, 22 | 13 | -7.14% |
| 31 Dec, 21 | 14 | - |
| 30 Sep, 21 | 14 | 55.56% |
| 30 Jun, 21 | 9 | -55.00% |
| 31 Mar, 21 | 20 | -16.67% |
| 31 Dec, 20 | 24 | 9.09% |
| 30 Sep, 20 | 22 | -48.84% |
| 30 Jun, 20 | 43 | 115.00% |
| 31 Mar, 20 | 20 | 25.00% |
| 31 Dec, 19 | 16 | 33.33% |
| 30 Sep, 19 | 12 | -7.69% |
| 30 Jun, 19 | 13 | 30.00% |
| 31 Mar, 19 | 10 | -16.67% |
| 31 Dec, 18 | 12 | -20.00% |
| 30 Sep, 18 | 15 | -42.31% |
| 30 Jun, 18 | 26 | -13.33% |
| 31 Mar, 18 | 30 | 25.00% |
| 31 Dec, 17 | 24 | - |
38 institutional shareholders have increased their position in SCPH stock as of 30 Jun 24 compared to 35 in the previous quarter (a 8.57% increase).
Institutional Reduced Positions Trend
| Date | Reduced Positions | Change % |
|---|---|---|
| 30 Jun, 24 | 21 | -30.00% |
| 31 Mar, 24 | 30 | 20.00% |
| 31 Dec, 23 | 25 | -10.71% |
| 30 Sep, 23 | 28 | 75.00% |
| 30 Jun, 23 | 16 | 6.67% |
| 31 Mar, 23 | 15 | 66.67% |
| 31 Dec, 22 | 9 | -30.77% |
| 30 Sep, 22 | 13 | 30.00% |
| 30 Jun, 22 | 10 | -23.08% |
| 31 Mar, 22 | 13 | 62.50% |
| 31 Dec, 21 | 8 | -27.27% |
| 30 Sep, 21 | 11 | -47.62% |
| 30 Jun, 21 | 21 | 50.00% |
| 31 Mar, 21 | 14 | 7.69% |
| 31 Dec, 20 | 13 | -23.53% |
| 30 Sep, 20 | 17 | 183.33% |
| 30 Jun, 20 | 6 | -14.29% |
| 31 Mar, 20 | 7 | 40.00% |
| 31 Dec, 19 | 5 | -28.57% |
| 30 Sep, 19 | 7 | -41.67% |
| 30 Jun, 19 | 12 | -14.29% |
| 31 Mar, 19 | 14 | 7.69% |
| 31 Dec, 18 | 13 | 116.67% |
| 30 Sep, 18 | 6 | 20.00% |
| 30 Jun, 18 | 5 | 25.00% |
| 31 Mar, 18 | 4 | - |
| 31 Dec, 17 | - | - |
21 institutional shareholders have reduced their position in SCPH stock as of 30 Jun 24 compared to 30 in the previous quarter (a -30.00% decrease).
All Institutional Ownership Trend Data
| Date | Holdings | Change % | Shares Outstanding | Change % | Ownership % | Change % | Increased Positions | Change % | Reduced Positions | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| 30 Jun, 24 | 73 | -9.88% | 27,715,856 | 3.66% | 71.15% | 1.50% | 38 | 8.57% | 21 | -30.00% |
| 31 Mar, 24 | 81 | -4.71% | 26,737,984 | -4.32% | 68.94% | 1.33% | 35 | -16.67% | 30 | 20.00% |
| 31 Dec, 23 | 85 | 10.39% | 27,946,038 | -6.54% | 72.10% | 1.21% | 42 | 40.00% | 25 | -10.71% |
| 30 Sep, 23 | 77 | -9.41% | 29,902,963 | 4.89% | 77.28% | 1.36% | 30 | -46.43% | 28 | 75.00% |
| 30 Jun, 23 | 85 | 28.79% | 28,507,710 | 15.99% | 75.42% | 1.78% | 56 | 43.59% | 16 | 6.67% |
| 31 Mar, 23 | 66 | 6.45% | 24,576,959 | 14.95% | 65.02% | 1.14% | 39 | -11.36% | 15 | 66.67% |
| 31 Dec, 22 | 62 | 58.97% | 21,381,300 | 52.65% | 75.40% | 2.89% | 44 | 238.46% | 9 | -30.77% |
| 30 Sep, 22 | 39 | 8.33% | 14,006,513 | -10.67% | 51.12% | 1.56% | 13 | -27.78% | 13 | 30.00% |
| 30 Jun, 22 | 36 | 2.86% | 15,679,691 | -1.28% | 57.27% | 1.70% | 18 | 38.46% | 10 | -23.08% |
| 31 Mar, 22 | 35 | 16.67% | 15,882,822 | -0.33% | 58.03% | 1.71% | 13 | -7.14% | 13 | 62.50% |
| 31 Dec, 21 | 30 | - | 15,935,870 | -1.81% | 58.25% | 1.65% | 14 | - | 8 | -27.27% |
| 30 Sep, 21 | 30 | -14.29% | 16,228,956 | 1.26% | 59.33% | 1.73% | 14 | 55.56% | 11 | -47.62% |
| 30 Jun, 21 | 35 | -22.22% | 16,027,686 | -6.55% | 58.59% | 1.49% | 9 | -55.00% | 21 | 50.00% |
| 31 Mar, 21 | 45 | -2.17% | 17,151,627 | 1.22% | 62.74% | 1.63% | 20 | -16.67% | 14 | 7.69% |
| 31 Dec, 20 | 46 | -8.00% | 16,944,425 | -0.87% | 62.02% | 1.58% | 24 | 9.09% | 13 | -23.53% |
| 30 Sep, 20 | 50 | -1.96% | 17,093,699 | -2.52% | 62.57% | 1.11% | 22 | -48.84% | 17 | 183.33% |
| 30 Jun, 20 | 51 | 59.38% | 17,536,484 | 40.42% | 75.09% | 1.97% | 43 | 115.00% | 6 | -14.29% |
| 31 Mar, 20 | 32 | 14.29% | 12,488,415 | 12.26% | 61.77% | 1.74% | 20 | 25.00% | 7 | 40.00% |
| 31 Dec, 19 | 28 | 12.00% | 11,124,578 | 46.81% | 59.61% | 3.59% | 16 | 33.33% | 5 | -28.57% |
| 30 Sep, 19 | 25 | -13.79% | 7,577,681 | 2.81% | 40.77% | 2.59% | 12 | -7.69% | 7 | -41.67% |
| 30 Jun, 19 | 29 | -9.38% | 7,370,592 | -1.52% | 39.67% | 2.44% | 13 | 30.00% | 12 | -14.29% |
| 31 Mar, 19 | 32 | -5.88% | 7,483,982 | -4.63% | 40.29% | 2.25% | 10 | -16.67% | 14 | 7.69% |
| 31 Dec, 18 | 34 | 6.25% | 7,847,513 | -2.60% | 42.29% | 2.25% | 12 | -20.00% | 13 | 116.67% |
| 30 Sep, 18 | 32 | -17.95% | 8,056,850 | -0.43% | 43.39% | 2.28% | 15 | -42.31% | 6 | 20.00% |
| 30 Jun, 18 | 39 | 2.63% | 8,091,983 | -2.75% | 43.62% | 2.16% | 26 | -13.33% | 5 | 25.00% |
| 31 Mar, 18 | 38 | 58.33% | 8,320,526 | 6.58% | 44.89% | 2.53% | 30 | 25.00% | 4 | - |
| 31 Dec, 17 | 24 | - | 7,806,737 | - | 42.12% | - | 24 | - | - | - |
scPharmaceuticals Insider Shareholders Trades
Open Market Insider Trades
Open Market Insider Buys
Insider Sells
All Insider Owners Trades
The last insider sell of scPharmaceuticals's stock was made by Nokes Rachael on Aug 08 2024, selling 10,445 shares at $1.66 per share (valued at $17.34K). The last insider buy of SCPH was made by ORBIMED ADVISORS LLC on Aug 15 2024, buying 478,342 shares at $4.00 per share (worth $1.91M).
scPharmaceuticals Insider Ownership Trends
All Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 3 | 1 | 300.00% |
| Q2 2024 | 8 | - | - |
| Q1 2024 | 5 | 2 | 250.00% |
| Q2 2023 | 8 | - | - |
| Q1 2023 | 4 | - | - |
| Q4 2022 | 4 | 14 | 28.57% |
| Q3 2022 | - | 7 | - |
| Q2 2022 | 13 | 4 | 325.00% |
| Q1 2022 | 2 | - | - |
| Q4 2021 | 2 | - | - |
| Q2 2021 | 7 | - | - |
| Q1 2021 | 3 | 3 | 100.00% |
| Q3 2020 | 1 | - | - |
| Q2 2020 | 13 | 2 | 650.00% |
| Q1 2020 | 4 | 1 | 400.00% |
| Q4 2019 | 1 | - | - |
| Q2 2019 | 9 | - | - |
| Q1 2019 | - | 6 | - |
| Q3 2018 | 2 | 1 | 200.00% |
| Q2 2018 | 7 | - | - |
3 total buy trades, and 1 total sell trades (buy/sell ratio of 3.00%) were made by scPharmaceuticals's insiders, as of Q3 2024.
Open Market Insider Trades Trend
| Date | Buy | Sell | Buy/Sell Ratio |
|---|---|---|---|
| Q3 2024 | 2 | - | - |
| Q2 2024 | - | - | - |
| Q1 2024 | - | - | - |
| Q2 2023 | - | - | - |
| Q1 2023 | - | - | - |
| Q4 2022 | 1 | 12 | 8.33% |
| Q3 2022 | - | 7 | - |
| Q2 2022 | - | 4 | - |
| Q1 2022 | - | - | - |
| Q4 2021 | 2 | - | - |
| Q2 2021 | - | - | - |
| Q1 2021 | - | 2 | - |
| Q3 2020 | - | - | - |
| Q2 2020 | 3 | - | - |
| Q1 2020 | 2 | - | - |
| Q4 2019 | 1 | - | - |
| Q2 2019 | 1 | - | - |
| Q1 2019 | - | - | - |
| Q3 2018 | - | - | - |
| Q2 2018 | - | - | - |
As of Q3 2024, Insider owners conducted 2 open market buy trades and 0 open market sell trades of scPharmaceuticals's stocks.
scPharmaceuticals Peer Ownership
| Ticker | Company |
|---|---|
| MNPR | Monopar Therapeutics Inc. |
| CNTA | Centessa Pharmaceuticals plc |
| IOVA | Iovance Biotherapeutics, Inc. |
| KTTA | Pasithea Therapeutics Corp. |
| MCRB | Seres Therapeutics, Inc. |
| SCPS | Scopus BioPharma Inc. |
| ONCY | Oncolytics Biotech Inc. |
| DMAC | DiaMedica Therapeutics Inc. |
| MIST | Milestone Pharmaceuticals Inc. |
| LIFE | aTyr Pharma, Inc. |
| LYRA | Lyra Therapeutics, Inc. |
SCPH Ownership FAQ
Who Owns scPharmaceuticals?
scPharmaceuticals is owned by institutional shareholders (71.15%), insiders (8.46%), and public (20.39%). The largest institutional shareholder of scPharmaceuticals is ORBIMED ADVISORS LLC (14.27% of total shares) and the top mutual fund owner is BRIDGEWAY FUNDS INC (0.08% of total shares).
Who are the major institutional shareholders of scPharmaceuticals?
scPharmaceuticals's major institutional shareholders are ORBIMED ADVISORS LLC, RUBRIC CAPITAL MANAGEMENT LP, AIGH CAPITAL MANAGEMENT LLC, KING LUTHER CAPITAL MANAGEMENT CORP, and BLACKROCK INC.. The top five shareholders own together 42.52% of the company's share outstanding.
How many scPharmaceuticals shareholders are there?
As of Jun 2024, there are 73 institutional shareholders of scPharmaceuticals.
What percentage of scPharmaceuticals is owned by ORBIMED ADVISORS LLC?
ORBIMED ADVISORS LLC owns 5.56M shares of scPharmaceuticals, representing 14.27% of the company's total shares outstanding, valued at $24.18M (as of Jun 2024).
What percentage of scPharmaceuticals is owned by RUBRIC CAPITAL MANAGEMENT LP?
As of Jun 2024, RUBRIC CAPITAL MANAGEMENT LP holds 3.52M shares of scPharmaceuticals (SCPH), compromising 9.05% of the company, valued at $15.33M.
What percentage of scPharmaceuticals is owned by AIGH CAPITAL MANAGEMENT LLC?
AIGH CAPITAL MANAGEMENT LLC is the third largest holder of scPharmaceuticals. The company owns 3.5M of the company's shares outstanding (worth $15.24M).